Transcription factor OCT4 promotes cell cycle progression by regulating CCND1 expression in esophageal carcinoma

被引:32
作者
Li, Zhigang [1 ]
Li, Xinxin [2 ]
Li, Chunguang [3 ]
Su, Yinghan [4 ]
Fang, Wentao [1 ]
Zhong, Chenxi [1 ]
Ji, Weidan [5 ,6 ]
Zhang, Qian [5 ,6 ]
Su, Changqing [5 ,6 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Esophageal Dis Ctr, Dept Thorac Surg, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai 200168, Peoples R China
[4] Xian Jiaotong Liverpool Univ, Dept Biol, Suzhou 215123, Peoples R China
[5] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Mol Oncol, Shanghai 200438, Peoples R China
[6] Second Mil Med Univ, Natl Ctr Liver Canc, Shanghai 200438, Peoples R China
基金
中国国家自然科学基金;
关键词
Cyclin; Transcription factor; Cell cycle; Gene expression; Esophageal cancer; D1; CANCER; ROLES;
D O I
10.1016/j.canlet.2014.07.049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The CCND1 gene is overexpressed in esophageal cancer and accelerates cell cycle progression. However, the mechanism whereby the upstream genes or factors directly regulate CCND1 expression remains unknown. By analyzing the 5'-UTR region of the CCND1 gene, we found that this region contains an octamer motif (ATTTTGCAT), which suggests that the expression of CCND1 might be directly associated with octamer-binding transcription factor 4 (OCT4). In this study, the wild-type and the octamer motif-mutanted CCND1 promoters were cloned, and their corresponding luciferase reporter vectors were then constructed to study the molecular mechanism by which OCT4 regulates the expression of CCND1 and influences the biological behaviors of esophageal cancer cells. The results indicated that suppressing the expression of CCND1 and OCT4 in esophageal cancer cells reduced cell proliferative and invasive abilities, induced cell cycle G1-phase arrest, and slowed the growth of xenografts in nude mice. Suppression of OCT4 expression significantly decreased the wild-type CCND1 promoter activity and down-regulated the expression of CCND1, but did not affect the activity of the mutant promoter. Whereas, suppression of CCND1 did not affect OCT4 expression, suggesting that OCT4 regulates CCND1 expression by activating the CCND1 promoter and subsequently promoting cell cycle progression. The results revealed and confirmed that OCT4 is the upstream factor that directly binds to the CCND1 promoter to regulate CCND1 expression, then to promote cell cycle progression and accelerate the proliferation and invasion of esophageal cancer cells. This finding may significantly contribute to elucidating the regulatory mechanism involved in the cell cycle progression of esophageal cancer cells and may aid in screening potential gene targets for the biological therapy of esophageal cancer. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 28 条
[1]   The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines [J].
Amini, Sabrieh ;
Fathi, Fardin ;
Mobalegi, Jafar ;
Sofimajidpour, Heshmatollah ;
Ghadimi, Tayyeb .
ANATOMY & CELL BIOLOGY, 2014, 47 (01) :1-11
[2]   Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1 [J].
Benzeno, S. ;
Lu, F. ;
Guo, M. ;
Barbash, O. ;
Zhang, F. ;
Herman, J. G. ;
Klein, P. S. ;
Rustgi, A. ;
Diehl, J. A. .
ONCOGENE, 2006, 25 (47) :6291-6303
[3]   Core transcriptional regulatory circuitry in human embryonic stem cells [J].
Boyer, LA ;
Lee, TI ;
Cole, MF ;
Johnstone, SE ;
Levine, SS ;
Zucker, JR ;
Guenther, MG ;
Kumar, RM ;
Murray, HL ;
Jenner, RG ;
Gifford, DK ;
Melton, DA ;
Jaenisch, R ;
Young, RA .
CELL, 2005, 122 (06) :947-956
[4]   Myc and cell cycle control [J].
Bretones, Gabriel ;
Dolores Delgado, M. ;
Leon, Javier .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (05) :506-516
[5]   OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma [J].
Cao, Lu ;
Li, Chunguang ;
Shen, Shuwen ;
Yan, Yan ;
Ji, Weidan ;
Wang, Jinghan ;
Qian, Haihua ;
Jiang, Xiaoqing ;
Li, Zhigang ;
Wu, Mengchao ;
Zhang, Ying ;
Su, Changqing .
BMC CANCER, 2013, 13
[6]   Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present [J].
Casimiro, Mathew C. ;
Velasco-Velazquez, Marco ;
Aguirre-Alvarado, Charmina ;
Pestell, Richard G. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) :295-304
[7]   Longer Survival in Patients with Breast Cancer with Cyclin D1 Over-Expression after Tumor Recurrence: Longer, but Occupied with Disease [J].
Chung, Jaesik ;
Noh, Hany ;
Park, Kwang Hwa ;
Choi, Eunhee ;
Han, Airi .
JOURNAL OF BREAST CANCER, 2014, 17 (01) :47-53
[8]   Signaling Pathways that Control Cell Proliferation [J].
Duronio, Robert J. ;
Xiong, Yue .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (03)
[9]   Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway [J].
Emhemmed, Fathi ;
Azouaou, Sarah Ali ;
Thuaud, Frederic ;
Schini-Kerth, Valerie ;
Desaubry, Laurent ;
Muller, Christian D. ;
Fuhrmann, Guy .
BIOCHEMICAL PHARMACOLOGY, 2014, 89 (02) :185-196
[10]   Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer [J].
Gu, Yanjun ;
Zhang, Shiwu ;
Wu, Qiang ;
Xu, Shaoyan ;
Cui, Yanfen ;
Yang, Zhengduo ;
Zhao, Xiulan ;
Sun, Baocun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29